FDA Import Refusal 1FX-3564313-8/40002/1 — Lek d.d.
The FDA refused shipment 1FX-3564313-8/40002/1 from Lek d.d. (Slovenia) on May 20, 2026. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 20, 2026
- Country
- Slovenia
- Product Category
- Drugs and Biologics
- Product Code
- 61JCA08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 118,3280